1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update. Circulation. 2010; 23; 121: e46-215.
2. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning and translational aspects of protective measures. Am J Physiol Heart Circul Physiol. 2011; 301: H1723-H1741. [
DOI:10.1152/ajpheart.00553.2011] [
PMID]
3. Kobayashi K, Maeda K, Takefuji M, et al. Dynamics of angiogenesis in ischemic areas of the infarcted heart. Scie Report. 2017; 7. [
DOI:10.1038/s41598-017-07524-x] [
PMID] [
PMCID]
4. Crosby JR, Kaminski WE, Schatteman G, et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circulation Res. 2000; 27; 87: 728-30. [
DOI:10.1161/01.RES.87.9.728] [
PMID]
5. Kang J, Yoon JK, Oh SJ, Kim BS, Kim SH. Synergistic therapeutic effect of three-dimensional stem cell clusters and angiopoietin-1 on promoting vascular regeneration in ischemic region. Tissue Eng Part A. 2017; [
DOI:10.1089/ten.tea.2017.0260] [
PMID]
6. Moore MA, Hattori K, Heissig B, et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector‐mediated elevation of serum levels of SDF‐1, VEGF, and angiopoietin‐1. Ann New York Academ Scie. 2001; 1; 938: 36-47. [
DOI:10.1111/j.1749-6632.2001.tb03572.x] [
PMID]
7. Chandrasekaran B, Kalra PR, Donovan J, Hooper J, Clague JR, McDonagh TA. Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction. J Cardiac Fail. 2010; 31; 16: 556-61. [
DOI:10.1016/j.cardfail.2010.02.004] [
PMID]
8. Wright D, Sutherland L. Exercise increases apelin expression in white adipose tissue: Med Sci Sport Exercise. 2009; 1; 41: 38. [
DOI:10.1249/01.mss.0000353380.58815.3d]
9. Li L, Zeng H, Chen JX. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circulat Physiol. 2012; 1; 303: H605-18. [
DOI:10.1152/ajpheart.00366.2012] [
PMID] [
PMCID]
10. Wu L, Chen L, Li L. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis. Clinica Chimica Acta. 2017; 1; 466: 78-84. [
DOI:10.1016/j.cca.2016.12.023] [
PMID]
11. Zeng XX, Wilm TP, Sepich DS, Solnica-Krezel L. Apelin and its receptor control heart field formation during zebrafish gastrulation. Develop Cell. 2007; 31; 12: 391-402. [
DOI:10.1016/j.devcel.2007.01.011] [
PMID]
12. Tempel D, de Boer M, van Deel ED, et al. Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells novelty and significance. Circulation Res. 2012; 17; 111: 585-98. [
DOI:10.1161/CIRCRESAHA.111.262097] [
PMID]
13. Ranjbar K, Nazem F, Nazari A, et al. Synergistic effects of nitric oxide and exercise on revascularisation in the infarcted ventricle in a murine model of myocardial infarction. EXCLI J. 2015; 14: 1104.
14. Kraljevic J, Marinovic J, Pravdic D, et al. Aerobic interval training attenuates remodelling and mitochondrial dysfunction in the post-infarction failing rat heart. Cardiovasc Res. 2013; 2: cvt080.
15. Høydal MA, Wisløff U, Kemi OJ, Ellingsen Ø. Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. Europ J Cardiovas Prevent Rehabil. 2007; 14: 753-60. [
DOI:10.1097/HJR.0b013e3281eacef1] [
PMID]
16. Wisløff U, Støylen A, Loennechen JP, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. Circulation. 2007 19; 115: 3086-94. [
DOI:10.1161/CIRCULATIONAHA.106.675041] [
PMID]
17. Zhao W, Zhao T, Chen Y, Ahokas RA, Sun Y. Reactive oxygen species promote angiogenesis in the infarcted rat heart. Int J Exper Pathol. 2009; 1; 90: 621-9. [
DOI:10.1111/j.1365-2613.2009.00682.x] [
PMID] [
PMCID]
18. El Nabi WM, Eman MS. The possible physiological role of vascular endothelial growth factor receptor-1 (VEGFR-1) in adrenaline-induced myocardial infarction in rats with and without exercise. J Am Sci. 2012; 8.
19. Green DJ, Smith KJ. Effects of exercise on vascular function, structure, and health in humans. Cold Spring Harbor Perspect Med. 2017: a029819. [
DOI:10.1101/cshperspect.a029819] [
PMID]
20. Hoier B, Hellsten Y. Exercise‐induced capillary growth in human skeletal muscle and the dynamics of VEGF. Microcirculation. 2014; 1; 21: 301-14. [
DOI:10.1111/micc.12117] [
PMID]
21. Tian Y, Gawlak G, O'Donnell JJ, Birukova AA, Birukov KG. Activation of vascular endothelial growth factor (VEGF) receptor 2 mediates endothelial permeability caused by cyclic stretch. J Biologic Chem. 2016: 6; 291: 10032-45. [
DOI:10.1074/jbc.M115.690487] [
PMID] [
PMCID]
22. Folkman J. Angiogenesis. Annu Rev Med. 2006; 18; 57: 1-8. [
DOI:10.1146/annurev.med.57.121304.131306] [
PMID]
23. Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1•25 million people. Lancet. 2014; 6; 383: 1899-911. [
DOI:10.1016/S0140-6736(14)60685-1]
24. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am College Cardiol. 2012; 13; 59: 969-78. [
DOI:10.1016/j.jacc.2011.07.054] [
PMID]
25. Xiao L, He H, Ma L, et al. Effects of miR-29a and miR-101a expression on myocardial interstitial collagen generation after aerobic exercise in myocardial-infarcted rats. Arch Med Res. 2017; 31; 48: 27-34. [
DOI:10.1016/j.arcmed.2017.01.006] [
PMID]
26. Pitkin SL, Maguire JJ, Kuc RE, Davenport AP. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol. 2010; 1; 160: 1785-95. [
DOI:10.1111/j.1476-5381.2010.00821.x] [
PMID] [
PMCID]
27. Atluri P, Morine K, Liao G, et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Molec Biol Lett. 2007; 1; 12: 127-38. [
DOI:10.2478/s11658-006-0058-7] [
PMID] [
PMCID]
28. Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Molec Cell Cardiol. 2006; 30; 41: 798-806. [
DOI:10.1016/j.yjmcc.2006.07.004] [
PMID]
29. Chen Z, Wu D, Li L, Chen L. Apelin/APJ system: a novel therapeutic target for myocardial ischemia/reperfusion injury. DNA Cell Biol. 2016; 1; 35: 766-75. [
DOI:10.1089/dna.2016.3391] [
PMID]